These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34382143)

  • 21. Development of a population pharmacokinetic/pharmacodynamic model for various oral paclitaxel formulations co-administered with ritonavir and thrombospondin-1 based on data from early phase clinical studies.
    van Eijk M; Yu H; Sawicki E; de Weger VA; Nuijen B; Dorlo TPC; Beijnen JH; Huitema ADR
    Cancer Chemother Pharmacol; 2022 Jul; 90(1):71-82. PubMed ID: 35799067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and Toxicities of Oral Docetaxel Formulations Co-Administered with Ritonavir in Phase I Trials.
    Vermunt M; Marchetti S; Beijnen J
    Clin Pharmacol; 2021; 13():21-32. PubMed ID: 33536797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efficiency and mechanism of a new absorption enhancer, malic acid, for enhancing the oral bioavailability of docetaxel.
    Guo XH; Ding F; Lian X; Cui W; Li Z; Xing Y
    Pharm Dev Technol; 2021 Jun; 26(5):592-598. PubMed ID: 33734909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Solubility enhancement effect at absorption site on bioavailability of ritonavir using liquisolid technique.
    Bonthagarala B; Dasari V; Kotra V
    Ther Deliv; 2019 May; 10(5):295-310. PubMed ID: 31094300
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug-interactive mPEG-
    Gong F; Wang R; Zhu Z; Duan J; Teng X; Cui ZK
    Drug Deliv; 2020 Dec; 27(1):238-247. PubMed ID: 32003299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. No relation between docetaxel administration route and high-grade diarrhea incidence.
    Hendrikx JJMA; Stuurman FE; Song JY; de Weger VA; Lagas JS; Rosing H; Beijnen JH; Schinkel AH; Schellens JHM; Marchetti S
    Pharmacol Res Perspect; 2020 Aug; 8(4):e00633. PubMed ID: 32725720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poloxamer-based solid dispersions for oral delivery of docetaxel: Differential effects of F68 and P85 on oral docetaxel bioavailability.
    Song CK; Yoon IS; Kim DD
    Int J Pharm; 2016 Jun; 507(1-2):102-8. PubMed ID: 27154250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biopharmaceutic
    Arora S; Pansari A; Kilford P; Jamei M; Gardner I; Turner DB
    Mol Pharm; 2020 Jul; 17(7):2329-2344. PubMed ID: 32427480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A dose-escalation study of bi-daily once weekly oral docetaxel either as ModraDoc001 or ModraDoc006 combined with ritonavir.
    de Weger VA; Stuurman FE; Hendrikx JJMA; Moes JJ; Sawicki E; Huitema ADR; Nuijen B; Thijssen B; Rosing H; Keessen M; Mergui-Roelvink M; Beijnen JH; Schellens JHM; Marchetti S
    Eur J Cancer; 2017 Nov; 86():217-225. PubMed ID: 29031170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infant formula as a solid lipid dose form for enhancement of the oral bioavailability of cannabidiol for paediatric patients.
    Huang S; Pham AC; Salim M; Eason T; Ramirez G; Boyd BJ
    Int J Pharm; 2024 Jul; 660():124257. PubMed ID: 38782154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a Tumour Growth Inhibition Model to Elucidate the Effects of Ritonavir on Intratumoural Metabolism and Anti-tumour Effect of Docetaxel in a Mouse Model for Hereditary Breast Cancer.
    Yu H; Hendrikx JJ; Rottenberg S; Schellens JH; Beijnen JH; Huitema AD
    AAPS J; 2016 Mar; 18(2):362-71. PubMed ID: 26603889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigating the influence of relevant pharmacogenetic variants on the pharmacokinetics and pharmacodynamics of orally administered docetaxel combined with ritonavir.
    van Eijk M; Pluim D; Dorlo TPC; Marchetti S; Huitema ADR; Beijnen JH
    Pharmacogenomics J; 2021 Jun; 21(3):336-345. PubMed ID: 33649517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solid self-microemulsifying drug delivery system of ritonavir.
    Deshmukh A; Kulkarni S
    Drug Dev Ind Pharm; 2014 Apr; 40(4):477-87. PubMed ID: 23465049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Phase 1 Study to Assess the Relative Bioavailability, Food Effect, and Safety of a Tablet Formulation of GSK2838232, a Novel HIV Maturation Inhibitor in Healthy Participants After Single and Repeated Doses.
    Johnson M; Jewell RC; Gan J; Dumont E; Burns O; Johns BA
    Clin Pharmacol Drug Dev; 2020 Nov; 9(8):972-977. PubMed ID: 32558338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current Development of Oral Taxane Formulations: A Review.
    Chowdhury N; Singh M
    Crit Rev Ther Drug Carrier Syst; 2020; 37(3):205-227. PubMed ID: 32749138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. P-gp modulatory acetyl-11-keto-β-boswellic acid based nanoemulsified carrier system for augmented oral chemotherapy of docetaxel.
    Pandey G; Mittapelly N; Valicherla GR; Shukla RP; Sharma S; Banala VT; Urandur S; Jajoriya AK; Mitra K; Mishra DP; Gayen JR; Mishra PR
    Colloids Surf B Biointerfaces; 2017 Jul; 155():276-286. PubMed ID: 28437753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Taxanes: old drugs, new oral formulations.
    Jibodh RA; Lagas JS; Nuijen B; Beijnen JH; Schellens JH
    Eur J Pharmacol; 2013 Oct; 717(1-3):40-6. PubMed ID: 23660368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral delivery system prolongs blood circulation of docetaxel nanocapsules via lymphatic absorption.
    Attili-Qadri S; Karra N; Nemirovski A; Schwob O; Talmon Y; Nassar T; Benita S
    Proc Natl Acad Sci U S A; 2013 Oct; 110(43):17498-503. PubMed ID: 24101508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel Gellan Gum-Based In Situ Nanovesicle Formulation of Docetaxel for Its Localized Delivery Using Depot Formation.
    Singh A; Thakur S; Singh N; Kaur S; Jain SK
    AAPS PharmSciTech; 2021 May; 22(5):165. PubMed ID: 34046797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Co-encapsulation of docetaxel and cyclosporin A into SNEDDS to promote oral cancer chemotherapy.
    Cui W; Zhao H; Wang C; Chen Y; Luo C; Zhang S; Sun B; He Z
    Drug Deliv; 2019 Dec; 26(1):542-550. PubMed ID: 31090467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.